SOPHiA GENETICS SA Net Change in Short-term Investments 2020-2025 | SOPH
SOPHiA GENETICS SA net change in short-term investments from 2020 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
| SOPHiA GENETICS SA Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $18 |
| 2022 | $79 |
| 2021 | $22 |
| 2020 | $N/A |
| 2019 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.200B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
| Hims & Hers Health (HIMS) | United States | $12.660B | 131.53 |
| Tempus AI (TEM) | United States | $9.553B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.485B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
| Privia Health (PRVA) | United States | $2.775B | 189.67 |
| Enovis (ENOV) | United States | $1.788B | 9.97 |
| Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Phreesia (PHR) | United States | $1.457B | 0.00 |
| Omnicell (OMCL) | United States | $1.423B | 25.10 |
| Azenta (AZTA) | United States | $1.223B | 56.85 |
| 10x Genomics (TXG) | United States | $1.173B | 0.00 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 159.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.384B | 0.00 |
| TruBridge (TBRG) | United States | $0.360B | 797.67 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |